India is the largest supplier of generic medicines in the world, exporting over USD 50 billion worth of pharmaceuticals annually. Indian generics fill approximately 40% of the US generic drug supply and reach patients in over 200 countries. But with recent reports of substandard drugs making headlines — in March 2026 alone, the CDSCO flagged 168 medicines as “Not of Standard Quality” (NSQ) — international buyers increasingly ask one critical question: How can I be sure the generic medicines I buy from India are safe and effective?
This practical guide answers that question. Whether you are a patient sourcing medicines for personal use or a healthcare provider evaluating suppliers, use this five-step framework to verify quality before you buy.
🔍 Step 1: Check CDSCO Registration and Drug Licence
The Central Drugs Standard Control Organization (CDSCO) is India’s national drug regulatory authority under the Ministry of Health and Family Welfare. Every legitimate drug manufacturer and exporter in India must hold a valid drug manufacturing license issued by CDSCO or the relevant state drug controller.
What to verify:
- Drug Manufacturing Licence (Form 25/28): Confirms the facility is approved to manufacture pharmaceutical products
- Wholesale or Distribution Licence (Form 20B/21B): Required for entities involved in trading or exporting
- Registered Office and Manufacturing Address: These must match the address listed on product packaging
As ETV Bharat reported in April 2026, CDSCO’s monthly quality monitoring program now publishes NSQ alerts publicly, giving buyers an independent check on manufacturers to avoid. You can search these alerts on the CDSCO website at cdsco.gov.in or through the Portals for Drug Alert system.
🏭 Step 2: Verify WHO-GMP Certification
The World Health Organization’s Good Manufacturing Practices (WHO-GMP) certification is the international gold standard for pharmaceutical quality. In India, the revised Schedule M of the Drugs and Cosmetics Rules — effective from December 2023 for large manufacturers and rolling out through 2024-2025 for small and medium units — mandates WHO-GMP compliance for drug manufacturing.
How to verify WHO-GMP status:
- Ask the supplier for their WHO-GMP certificate issued by the state drug controller
- Cross-check the certificate number and validity with the state licensing authority
- Check if the certificate covers the specific product you are buying — some certificates are product-specific
- Look for WHO-GMP logo on the product packaging (though not all legitimate products display it)
The Indian Express noted in August 2023 that India’s revised GMP rules are designed to “bring India at par with global standards” and support the country’s ambition as the world’s manufacturing hub for generics.
🇺🇸 Step 3: Review US FDA Inspection History (If Exporting to the US)
Indian generic manufacturers exporting to the US market are regularly inspected by the US FDA. These inspections are the most transparent quality checkpoint available. The US FDA publishes all inspection results, including Form 483 observations and Warning Letters, on its public database.
What to check:
- Visit the US FDA Inspection Classification Database (accessible at fda.gov/inspections-classification)
- Search by the manufacturer’s name or facility address
- Look for NAI (No Action Indicated) status — the best outcome
- If a VAI (Voluntary Action Indicated) or OAI (Official Action Indicated) appears, investigate the specific observations
- A recent clean FDA inspection is a strong signal that the manufacturer maintains high standards
Major Indian generic companies — including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Aurobindo Pharma, and Lupin — maintain active US FDA registrations and undergo regular facility inspections. Their public inspection records provide a useful benchmark for any supplier you are evaluating.
📋 Step 4: Request Product-Specific Documentation
Before making a purchase, a reputable Indian generic drug supplier should be able to provide the following documents on request. If a supplier hesitates or cannot produce these, consider it a red flag.
- Certificate of Analysis (CoA): Shows the batch-specific test results for potency, purity, dissolution, and impurities
- Batch Manufacturing Record: Summarises the production process and quality checks for that specific batch
- Stability Study Data: Demonstrates that the product maintains its potency and safety through its stated shelf life
- WHO-GMP Certificate: As discussed in Step 2
- Free Sale Certificate: Issued by CDSCO or state drug authority confirming the product is legally sold in India
- Export Invoice and Packing List: Should include batch number, manufacturing date, and expiry date for traceability
A comprehensive CoA from a WHO-GMP certified manufacturer will typically reference the Indian Pharmacopoeia (IP) or British Pharmacopoeia (BP) standard the product is tested against.
🛡️ Step 5: Buy from Verified and Trusted Distributors
The most important safeguard — especially for international buyers — is sourcing from a verified distributor with a track record of quality compliance. The Indian Drug Manufacturers’ Association and IMSDA maintain member networks of compliant exporters.
For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory. Every member listed there has been vetted for legitimate licensing and operational credibility.
Additional buyer safeguards:
- Use secure payment methods that offer buyer protection
- Request product samples before placing bulk orders
- Consider independent third-party lab testing for high-value orders
- Check the product packaging for proper labeling: drug name, composition, batch number, manufacturing date, expiry date, MRP, and manufacturer details
- Be wary of prices that are significantly below market rates — extreme discounts are often a red flag
📊 Recent Quality Alerts: What to Learn from the Data
In March 2026, CDSCO flagged 168 medicines as “Not of Standard Quality,” as reported by ETV Bharat. While this number may seem alarming, it reflects a strengthening regulatory system that is increasingly willing to identify and publicly name non-compliant products. A similar report by Frontline Magazine highlighted that India’s drug quality challenge is less about counterfeit “fake” medicines and more about substandard manufacturing — medicines that fail quality testing due to improper formulation, contamination, or poor storage.
The key takeaway: India’s regulatory enforcement is improving, and the vast majority of WHO-GMP certified manufacturers produce safe, effective generics that meet international standards. The risks are concentrated among uncertified or poorly regulated manufacturers.
✅ Quick Checklist: Before You Buy Indian Generics
- ✅ Manufacturer has a valid CDSCO drug manufacturing licence (Form 25/28)
- ✅ Manufacturer holds current WHO-GMP certification
- ✅ US FDA inspection history (if exporting to US) shows NAI status or minor VAI only
- ✅ Supplier provides Certificate of Analysis (CoA) for each batch
- ✅ Product packaging displays clear batch number, mfg/expiry dates, manufacturer details
- ✅ Supplier is a verified member of industry associations like IMSDA
- ✅ Pricing is realistic and competitive — not suspiciously cheap
- ✅ You have a direct point of contact who can answer quality questions
📝 Summary
Indian generic medicines are safe, effective, and affordable when sourced from regulated, WHO-GMP certified manufacturers. The vast majority of India’s drug export industry — valued at over USD 50 billion — operates under CDSCO oversight and meets international quality standards. By following the five-step verification framework in this guide — checking CDSCO licensing, WHO-GMP status, US FDA records, product documentation, and distributor credentials — you can confidently source generics from India without compromising on quality.
For more information, contact IMSDA at contact@indiamedicine.org.